Sarah Pringle

Sarah Pringle is a senior reporter focused on M&A, private equity and auctions in the healthcare industry. Prior to joining The Deal, Pringle reported on U.S. and Canadian equity markets at Bloomberg News in New York and MarketWatch in San Francisco.

Recent Articles By The Author

2 Oversold Health Care Service Stocks in Wake of Community Health Review

2 Oversold Health Care Service Stocks in Wake of Community Health Review

Rural hospital operators have already been implicated, but the review is pushing down other services companies too far and may present buying opportunities.

Struggling Hospital Cos. Quorum, LifePoint Next Up in Consolidation Push

Struggling Hospital Cos. Quorum, LifePoint Next Up in Consolidation Push

Activists could take interest in the challenged group of non-urban hospital operators as they continue to disappoint investors.

Takeover Chatter Around Clovis May Be Overdone

Takeover Chatter Around Clovis May Be Overdone

Rumors are swirling about Big Pharma interest in the cancer drug developer, but the validity of such theories is questioned by at least some company followers.

Allergan's Vitae Buy Could Spark More Interest in Kadmon

Allergan's Vitae Buy Could Spark More Interest in Kadmon

Hedge fund billionaire Dan Loeb owns a greater than 17% stake in the newly public developer of a drugs including those for treatment of psoriasis.

Community Health Draws Interest as Hospital Sector Appears Ripe for LBO Wave

Community Health Draws Interest as Hospital Sector Appears Ripe for LBO Wave

Community Health looks like a logical LBO candidate with shares having lost significant value since completing its spin off of Quorum Health in April.